Drugmakers, insurers, hospitals, pharmacies, medical devices, clinical updates, and healthcare business leaders.
Balbale, who had served as chief merchandising officer for about four years, exits as CVS reorganizes the interim leadership of its merchandising function.
THE APEX TIMES
THE APEX TIMES
HCA Healthcare said its first-quarter 2026 adjusted EBITDA came in weaker than expected, while the company also disclosed workforce cuts, sending its stock lower on the news.
THE APEX TIMES
The verdict stems from a lawsuit alleging pleural mesothelioma caused by years of exposure to asbestos-contaminated talc linked to the company’s baby powder products.
THE APEX TIMES
After recent share weakness, RBC Capital Markets said Pfizer’s outlook offers a more balanced mix of potential upside and downside, pointing to two upcoming catalysts in the company’s pipeline.
THE APEX TIMES
As part of a new national awareness push, Eli Lilly is having Shaquille O’Neal share his experience with obstructive sleep apnea and discuss that weight-management treatment options may help address the condition.
THE APEX TIMES
On Mad Money, the host pointed to Johnson & Johnson’s drug profitability and balance-sheet strength, arguing that diversification can help investors weather sell-offs, though he did not spell out new-drug details in the reported segment.
THE APEX TIMES
The agreement gives Lilly rights to AlzeCure’s ACD680, a small-molecule gamma-secretase modulator designed to shift amyloid-beta production, as the company deepens its Alzheimer’s pipeline beyond its approved anti-amyloid therapy Kisunla.
THE APEX TIMES
Market coverage highlighted that UnitedHealth Group’s next ex-dividend date is expected within days, a timing that can affect which shareholders receive the upcoming cash payout.
THE APEX TIMES
A widely circulated market note argues Pfizer’s shares could re-rate toward $50 if multiple expansion returns, even as revenue declines tied to Comirnaty and Paxlovid continue to weigh on sentiment.
